<DOC>
	<DOC>NCT00803777</DOC>
	<brief_summary>The purpose of this study is to evaluate the performance and acceptability of a new blood glucose meter.</brief_summary>
	<brief_title>In-Clinic and Home-Use Study of a New Blood Glucose Monitoring System</brief_title>
	<detailed_description />
	<criteria>Type 1 diabetes Age 4 to 24 years Routinely performs blood glucose testing at home, at least 2 times per day, for one month or more before enrollment Has used a handheld game system to play video games within a year of enrollment If above age 18, subject is able to speak, read, and understand English. If below age 18, subject's parent/guardian is able to speak, read, and understand English, and is able to provide appropriate supervision. Is willing to complete all study procedures, with appropriate parent/guardian supervision Hemophilia or any other bleeding disorder Taking prescription anticoagulants (such as Warfarin or heparin) or has clotting problems that may prolong bleeding. Taking Plavix or aspirin daily is not excluded Infection with a blood borne pathogen (e.g., HIV, hepatitis) Subject or parent/guardian is employee of competitive medical device company Cognitive disorder or other condition, which in the opinion of the investigator, would put the person at risk or seriously compromise the integrity of the study</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>24 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>